DZM

Cơ điện Dzĩ An ·UPCOM ·2024Q4

▲ Showing improvement

Operating efficiency is improving Net margin −1.08%, +26.00pp YoY
Price
Latest close
P/E
P/B
EPS -43
BVPS -1,295
ROE 5.0%
ROA -0.4%
Profit Margin -1.1%
Asset Turnover 0.34x
Equity Mult. -13.89x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2024Q4 basis, DZM posted a sharp profit increase versus the same period, suggesting a clear improvement from a low base — margins have been expanding consistently over multiple periods. However, most of the profit comes from non-core sources — this needs careful evaluation before concluding on growth quality.

TTM REVENUE
VND 21bn
−14.1%YoY
NET MARGIN
−1.08%
+26.0ppYoY
TTM NET PROFIT
−VND 0bn
+96.6%YoY
Non-core income / PBT
213.4%
Metric Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23 Q1'23 Q4'22 Q3'22 Q2'22 Q1'22
Revenue 9.3 9.0 1.1 2.0 8.7 1.8 1.2 13.3 15.8 2.7 12.5 1.4
Growth +3% +715% -45% -77% +394% +43% -91% -16% +476% -78% +814%
Net Income 0.7 1.7 -1.2 -1.5 -0.2 -2.4 -2.2 -2.0 -2.6 -2.2 -0.8 -3.0
Net Margin 8.01% 18.80% -106.31% -74.35% -2.42% -134.72% -182.66% -14.67% -16.61% -80.54% -6.33% -223.13%

Drivers of DZM's profit

TTM

Net profit attributable to parent increased vs last year, mainly helped by lower administrative expenses. Supporting and offsetting drivers:

Administrative expenses ↓ 3.5bn
Finance costs ↓ 1.7bn
Gross profit ↑ 1.4bn
TTM

Net profit attributable to parent increased vs prior quarter, mainly helped by lower administrative expenses. Supporting and offsetting drivers:

Administrative expenses ↓ 1.0bn
Other profit ↓ 0.1bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2023Q4 -38.5% = -27.1% × 0.28 × 5.15
2024Q4 5.0% = -1.1% × 0.34 × -13.89

ROE rose from -38.5% to 5.0% — mainly driven by net margin, despite leverage moving in the opposite direction.

Net margin: -1.1% +26.0pp Asset turnover: 0.34x +0.06x Leverage: -13.89x -19.04x

Is the profit sustainable?

Margins improved (+26.0pp), but earnings still rely significantly on non-core sources — warrants closer scrutiny.

very positive positive stable watch under pressure

What is driving the margin?

Net margin expanded to -1.08%, rising 26.0pp. The main driver is SG&A / Revenue fell 12.2pp and Gross margin rose 8.8pp, moving in line with the stronger net margin (in addition, Net financial result / Revenue rose 7.0pp added support while Other profit / Revenue fell 2.0pp remained a drag).

The improvement comes from core operations — this is a high-quality margin expansion.

Profitability trend

Net Margin -1.08% +26.0pp
Gross Margin 23.61% +8.8pp
SG&A / Revenue 21.61% −12.2pp
Non-core / Revenue -3.08% +5.0pp

TTM YoY · 2023Q4 -> 2024Q4

Watchpoints

Other income is supporting margin

Other income accounts for 285.4% of PBT and lifted net margin by 5.0pp — separate the operating contribution from this source.

Is capital being used efficiently?

Return on capital rose, but cash cycle lengthened by 157.6 days — working capital needs watching.

Is capital being deployed efficiently?

ROIC expanded to 1.12%, rising 14.8pp. That translates to 1.12 in after-tax operating profit for every 100 units of operating capital. Both NOPAT margin rose 28.0pp and capital turnover rose 0.41x, with invested capital holding roughly steady — capital-return quality improved from both sides.

NOPAT margin led the improvement, but the ROIC level has not yet cleared typical cost of capital — margin needs to hold in coming periods rather than being a one-period rebound.

Watchpoints

ROIC remains low

ROIC is currently 1.12% — below the typical cost-of-capital threshold; worth tracking whether upcoming periods can rise above this level.

CAPITAL EFFICIENCY TREND

TTM YoY · 2023Q4 -> 2024Q4

ROIC 1.12% +14.8pp
NOPAT Margin 1.22% +28.0pp
Capital Turnover 0.92x +0.41x
Average Invested Capital 23.3bn −25.8bn

Balance Sheet

ROIC is improving — the asset structure below shows how capital is being allocated. Balance sheet is exceptionally sound — liabilities at -8.87x equity, with a net cash position equivalent to 3.16x equity.

Inventory ended the period at 32.1bn, roughly 54.2% of total assets.

Over the last 12 months, working capital absorbed 1.7bn of cash, mainly because of higher inventories. Part of that drag was offset by lower receivables and higher payables.

Working Capital Drivers

TTM YoY · 2023Q4 -> 2024Q4

Receivables decreased → higher CFO: +2.2bn
Inventories increased → lower CFO: −9.9bn
Payables increased → higher CFO: +6.0bn

Working Capital Efficiency

Cash conversion cycle lengthened by 157.6 days versus the same period last year. The main moves came from DIO rose 154.4 days, DSO rose 114.8 days, and DPO rose 111.6 days.

Working capital cycle lengthened mainly due to slower inventory turnover — more capital is being tied up in inventory.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 1122.3 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +114.8 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2023Q4 -> 2024Q4

Receivables 854.5 days +114.8 days
Inventory 612.6 days +154.4 days
Payables 344.8 days +111.6 days
Cash Conversion Cycle 1122.3 days +157.6 days

Is financial risk significant?

Leverage is safe but FCF is negative at 2.4bn due to capex of 0.0bn — an investment choice, not an urgent risk.

Leverage & Liquidity

Leverage warrants monitoring, with net debt / equity at -3.16x and interest coverage only at 1.19x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 0.6% of debt, and total debt stands at 23.9bn.

Watchpoints

Interest coverage is thin

Interest coverage is 1.19x, leaving limited room to absorb financing costs.

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Leverage and liquidity trend

Net Debt / Equity -3.16x +15.91x
Interest Coverage 1.19x +4.62x
Cash / Debt 0.6% −3.6pp
Short-term Debt / Total Debt 100.0% 0.0pp
CFO / NI 10.43x +10.84x

TTM YoY · 2023Q4 -> 2024Q4

Cash Flow

Operating cash flow reached -2.4bn in 2024, against investing cash flow of 0.4bn.

Post-investment cash flow was negative +2.0bn. Financing cash flow was positive +0.8bn.

CFO / net income was 10.43x.

After spending 0.0bn on fixed-asset investment, the business generated trailing free cash flow of −2.4bn.

Cash Conversion

TTM Cash Conversion · 2023Q4 -> 2024Q4

CFO TTM 2.4bn −5.2bn
Cash Capex 0.0bn 0.0bn
FCF TTM −2.4bn −5.2bn

Investment Takeaway

The business is heading the right way, but the current picture is still at partial confirmation — not yet a fully clean case. The positive points have clearly improved, showing the operating base is better than before. The brighter spot is operating efficiency, with net margin improving 26.0 pp. Even so, earnings quality still needs closer monitoring because net financial result remains elevated. The main risk still sits in capital efficiency remains weak, with ROIC at 1.1%.

Improvement: operating efficiency is getting better, with trailing-12M net margin at -1.08% after expanding 26.0pp versus the same period last year.

Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 10.43x. Even so, net financial result still accounts for 72.0% of PBT, so the earnings mix still needs monitoring.

Key risk: Capital efficiency remains weak.

Statement Data

Item 2024 2023 2022 2021 2020
Net Revenue
21.4 24.9 32.4 44.5 159.5
Cost of Goods Sold
17.2 21.2 23.6 0.0 0.0
Gross Profit
4.2 3.7 8.7 2.9 16.5
Financial Expenses
0.2 0.2 7.7 -1.5 -1.8
Selling Expenses
2.5 2.9 4.2 -3.5 -5.4
General and Administrative Expenses
2.2 4.7 4.7 -7.3 -8.1
Operating Profit
-0.7 -4.0 -7.7 -9.2 1.8
Profit Before Tax
-0.9 -4.1 -7.7 -9.8 1.5
Net Income
-0.9 -4.1 -7.7 -9.8 1.5
Profit Attributable to Parent
-0.9 -4.1 -7.7 -9.8 1.5
Earnings per Share
-168.00 -752.00 -1,434.00 -1,817.00 280.00

Explore Other Stocks In The Same Sector

SHI, CKA, AMS, CTB, PVM, QHD, HLO, MIE, CTT, SHA, SHE, EMG, TCK, CMC, IME, CJC, UEM, CMK

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.